Gene expression profiling and cancer-related pathways in Type I endometrial carcinoma

International Journal of Gynecological Cancer

Volumn 20, Issue 5, 2010, Pages 724-731

  Saghir, Fatma S A ^a   Rose, Isa Mohamed ^a   Dali, Ahmad Zailani Hatta Mohd ^b   Shamsuddin, Zainab ^c   Jamal, A Rahman A ^b   Mokhtar, Norfilza Mohd ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

Gene expression; Genomics; Microarray; Pathway analysis; Type I endometrial carcinoma

Indexed keywords

CAVEOLIN 1; CXCL 17 CHEMOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; PROTEIN ELF3; PROTEIN KINASE C ALPHA; STAT5 PROTEIN; TRANSFORMING GROWTH FACTOR A RECEPTOR III; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CLINICAL ARTICLE; DOWN REGULATION; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ERYTHROLEUKEMIA; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; HYBRIDIZATION; MICROARRAY ANALYSIS; ONCOGENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; VALIDATION PROCESS;

ADULT; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 77956856404     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181e1c14c     Document Type: Article

References (20)

1. Ferguson SE, Olshen AB, Levine DA, et al. Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecol Oncol. 2006;101:209Y213.
2. Kok Ying N, Ganesalingam M, Sabaratnam S. In: Lim GCC, Rampal S, Halimah Y, eds. Cancer Incidence in Peninsular Malaysia. Kuala Lumpur: National Cancer Registry. 2008:1Y286.
3. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366:491Y505.
4. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: From a phenotypical to a molecular-based classification. Virchows Arch. 2004;444: 213Y223.
5. Black D, Soslow RA, Levine DA, et al. Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. J Clin Oncol. 2006;24:1745Y1753.
6. Schlosshauer PW, Ellenson LH, Soslow RA. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Mod Pathol. 2002;15:1032Y1037.
7. Butte A. The use and analysis of microarray data. Nat Rev Drug Discov. 2002;1:951Y960.
8. Risinger JI, Maxwell GL, Chandramouli GV, et al. Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res. 2003;63:6Y11.
9. Moreno-Bueno G, Sanchez-Estevez C, Cassia R, et al. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res. 2003;63:5697Y5702.
10. Mutter GL, Baak JP, Fitzgerald JT, et al. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol. 2001;83:177Y185.
11. Maxwell GL, Chandramouli GV, Dainty L, et al. Microarray analysis of endometrial carcinomas and mixed Mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin Cancer Res. 2005;11:4056Y4066.
12. Maatta JA, Sundvall M, Junttila TT, et al. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Mol Biol Cell. 2006;17:67Y79.
13. Rokavec M, Justenhoven C, Schroth W, et al. A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk. Clin Cancer Res. 2007;13:7506Y7514.
14. Chobotova K, Karpovich N, Carver J, et al. Heparin-binding epidermal growth factor and its receptors mediate decidualization and potentiate survival of human endometrial stromal cells. J Clin Endocrinol Metab. 2005;90:913Y919.
15. Hughes DP, Thomas DG, Giordano TJ, et al. Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma. Cancer Res. 2004;64:2047Y2053.
16. Fox EM, Bernaciak TM, Wen J, et al. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Mol Endocrinol. 2008;22:1781Y1796.
17. Castanares C, Redondo-Horcajo M, Magan-Marchal N, et al. Transforming growth factor-beta receptor requirements for the induction of the endothelin-1 gene. Exp Biol Med (Maywood). 2006;231:700Y703.
18. Rodriguez GC, Rimel BJ, Watkin W, et al. Progestin treatment induces apoptosis and modulates transforming growth factor-beta in the uterine endometrium. Cancer Epidemiol Biomarkers Prev. 2008;17:578Y584.
19. Galvez BG, Matias-Roman S, Yanez-Mo M, et al. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell. 2004;15: 678Y687.
20. Tahir SA, Yang G, Goltsov AA, et al. Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer. Cancer Res. 2008;68:731Y739.